Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2006-12-18
pubmed:abstractText
The Rho family of GTPases regulates many aspects of cellular behavior through alterations to the actin cytoskeleton . The majority of the Rho family proteins function as molecular switches cycling between the active, GTP-bound and the inactive, GDP-bound conformations . Unlike typical Rho-family proteins, the Rnd subfamily members, including Rnd1, Rnd2, RhoE (also known as Rnd3), and RhoH, are GTPase deficient and are thus expected to be constitutively active . Here, we identify an unexpected role for RhoE/Rnd3 in the regulation of the p53-mediated stress response. We show that RhoE is a transcriptional p53 target gene and that genotoxic stress triggers actin depolymerization, resulting in actin-stress-fiber disassembly through p53-dependent RhoE induction. Silencing of RhoE induction in response to genotoxic stress maintains stress fiber formation and strikingly increases apoptosis, implying an antagonistic role for RhoE in p53-dependent apoptosis. We found that RhoE inhibits ROCK I (Rho-associated kinase I) activity during genotoxic stress and thereby suppresses apoptosis. We demonstrate that the p53-mediated induction of RhoE in response to DNA damage favors cell survival partly through inhibition of ROCK I-mediated apoptosis. Thus, RhoE is anticipated to function by regulating ROCK I signaling to control the balance between cell survival and cell death in response to genotoxic stress.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-11093808, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-11283606, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-11283607, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-11973608, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12101119, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12478284, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12480336, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12535859, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12635176, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12773565, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-12865435, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-13678607, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-15122349, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-15340047, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-15657395, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-15754346, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-15775972, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-16129889, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-16390872, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-16407310, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-16493413, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-16983089, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-8242752, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-8649376, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-8780694, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-8895530, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-9531558, http://linkedlifedata.com/resource/pubmed/commentcorrection/17174923-9671486
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0960-9822
pubmed:author
pubmed:issnType
Print
pubmed:day
19
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2466-72
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed-meshheading:17174923-Animals, pubmed-meshheading:17174923-Apoptosis, pubmed-meshheading:17174923-Cell Line, pubmed-meshheading:17174923-Cell Line, Tumor, pubmed-meshheading:17174923-Cell Survival, pubmed-meshheading:17174923-DNA Damage, pubmed-meshheading:17174923-Fibroblasts, pubmed-meshheading:17174923-Gene Expression Profiling, pubmed-meshheading:17174923-Genes, p53, pubmed-meshheading:17174923-Humans, pubmed-meshheading:17174923-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:17174923-Mice, pubmed-meshheading:17174923-Protein-Serine-Threonine Kinases, pubmed-meshheading:17174923-Signal Transduction, pubmed-meshheading:17174923-Tumor Suppressor Protein p53, pubmed-meshheading:17174923-Up-Regulation, pubmed-meshheading:17174923-rho GTP-Binding Proteins, pubmed-meshheading:17174923-rho-Associated Kinases
pubmed:year
2006
pubmed:articleTitle
RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress.
pubmed:affiliation
Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural